Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of January 13th – 19th, 2020.
Without further ado, let’s get started.
10. Analysts Are Forecasting a Cannabis Comeback in 2020, These Pot Stocks Could Lead the Charge
These Pot Stocks Received BUY Ratings and Bullish Price Targets Up to 185% Above Market
After 2019’s market shakeout, analysts say the right U.S. and Canadian Cannabis Stocks will rise in 2020. These Pot Stocks could deliver major gains by taking advantage of their financial position and competitive edge in 2020.
READ FULL CANNABIS COMEBACK ARTICLE
9. TransCanna Reports Another Strong Month of Revenue Growth, TCAN Stock Up 300% Since End of October
TCAN Stock is Forming a Bullish Chart Pattern with the Potential for Another Large Breakout
TransCanna Holdings TCAN TCNAF TH announced that its December revenue grew 20% month over month with net income from operations accounting for 16%. TCAN stock has been on a tear over the past 2.5 months soaring as much as 436%. The stock has recently pulled back and could be setting up for another large move to the upside.
8. Did MedMen Just Go Bankrupt?
Rumours Are Swirling That MMEN is Reaching Out to Debtholders to Negotiate Restructuring the Company
Medmen Enterprises MMEN MMNNF 0JS is rumoured to be offering $0.50 on the dollar to owners of MedMen debt and telling certain service providers that they aren’t able to pay outstanding bills.
7. Canopy Growth Revises Cannabis Beverage Launch Timeline
CGC Says Scaling Process is Not Complete, Delays Beverage Launch
Canopy Growth WEED CGC (FRA: 11L1) management remains very confident in the underlying beverage science and in its ability to scale production and deliver high quality, differentiated cannabis beverages to the market. However, the scaling process is not complete, and the company is extending its to-market date while the internal teams complete the final steps.
READ FULL CANOPY GROWTH ARTICLE
6. Aphria Reports Q2 Earnings and Revised 2020 Guidance
Adjusted EBITDA Soars 155% + APHA Stock Chart Review
Aphria APHA APHA (FRA: 10E) announced earnings for the second quarter ended November 30, 2019, with the company recording its third straight quarter of positive adjusted EBITDA. The company also lowered its fiscal 2020 earnings forecast.
5. Curaleaf Announces Closing of Upsized $300 Million Senior Loan Facility
The Deal Strengthens Curaleaf’s Balance Sheet and Liquidity
Curaleaf Holdings CURA CURLF announced the upsizing and closing of a senior secured term loan facility from a syndicate of lenders totalling US$300 million. The notes bear interest at a rate of 13.0% and will not dilute the company’s shareholders.
4. Inverse Head and Shoulders Pattern: 2 Cannabis Stocks With Big Breakouts and Trend Reversals
These Pot Stocks Broke Out in a Big Way as Technical Traders Piled In, Here Are the Price Targets
Two of the largest Marijuana Stocks in the industry added further confirmation that the sector has bottomed out. Canopy Growth WEED CGC (FRA: 11L1) and GW Pharma GWPH are sector bellwethers, meaning they are leading indicators and will usually move first before the rest of the group follows suit. Learn more about the Inverse Head and Shoulders chart pattern and the formula used for calculating price targets.
3. 4 of the Most Profitable Pot Stocks in 2020
The following four Pot Stocks should be among the most profitable this year: Trulieve Cannabis TRUL TCNNF, Innovative Industrial Properties IIPR, The Valens Company VLNS VLNCF and Harvest Health HARV HRVSF.
READ FULL PROFITABLE POT STOCKS ARTICLE
2. Analysts Make Adjustments to Organigram and Aphria’s Ratings and Price Targets Following Earnings
Two of Canada’s premier licensed producers (LPs) released quarterly earnings this week. Aphria APHA APHA (FRA: 10E) reported earnings for Q2 2020 while Organigram Holdings OGI OGI 0OG released its first-quarter 2020 financial results. Here’s what analysts had to say about APHA and OGI’s financial results.
1. Organigram Skyrockets Following Strong Q1 Earnings, Here’s Why OGI Stock Has Officially Bottomed
Shares of OGI Surged 44% in Reaction to the Results While Pot Stocks Across the Board Soared
Organigram Holdings OGI OGI 0OG announced earnings for the first quarter ended November 30, 2019, highlighted by a 102% increase in net revenue. This reliable technical indicator signalled the reversal of OGI’s downtrend 2 days before the stock’s big breakout.
Image Sourced from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!